New in MMWR: Medication for Opioid Use Disorder During Pregnancy

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

MMWR Surveillance Summaries: Vol. 72, May 5, 2023

May 5, 2023

SURVEILLANCE SUMMARIES

Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021 MAT-LINK is the first surveillance system to collect comprehensive, longitudinal data on pregnant person–infant dyads with perinatal outcomes associated with medication for opioid use disorder during pregnancy from multiple clinical sites.

READ MORE

PDF of this Surveillance Summaries (link).

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |